$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Abstract

Objective : Until now, there have been no evidence-based guidelines produced for the mass screening of hyperlipidemia cases in Korea. This study was done to find the most efficient strategy for a hyperlipidemia-screening program among Korean adults, Method : Seven alternative strategies for hyperlipidemia screening were formulated and compared ir terms of cost-effectiveness. Cost and effectiveness were estimated from social perspectives and using a two-stage screening process (initial testing and additional testing for positives from the first test). A computerized database (based on persons who had visited a health promotion center in one teaching hospital for a routine health check-up) was used to determine the cost and the outcome of various strategies. Official data was used in calculating direct and indirect costs. Effectiveness was measured according to the number of persons who needed clinical intervention for hyperlipidemia. A stratified analysis, considering age group and sex, was then done. Sensitivity analyses, focusing on several uncertain parameters, were also done. Results : Of the seven test alternatives available, the most cost-effective strategy was a screening program, which consisted of an initial test of total cholesterol, high-density lipoprotein cholesterol and triglyceride. There was some variation in the rank of the cost-effectiveness ratios for the seven alternatives dependent on age group or gender. Conclusions : Current hyperlipidemia screening practice, for National Health Insurance beneficiaries, tests only the total cholesterol level with a cut-off value of 260mg/dl as an initial screening test. It is not the best strategy for cost-effectiveness, and should be modified. Different screening strategies taking age group and sex into account should be developed and used for the efficient mass screening of hyperlipidemia cases among Korean adults.

참고문헌 (21)

  1. 통계청. 1998년 사망원인 통계 연보. 1999 
  2. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J, Wentworth D. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992; 152(7): 1490-1500 
  3. 의료보험관리공단. 피보험자 건강진단 분석. 1981, 1991, 1999 
  4. 김정순. 한국인 허혈성 심질환의 사망률 및 유병률과 그 위험요인. 제14차 한국지질학회 추계 학술대회 초록집. 1999 
  5. 보건복지부. 건강진단 실시 기준. 보건복지부 고시 제1999-45호. 1999 
  6. National Cholesterol Education Program Expert Panel. Summary of the second report of the National Cholesterol Education Program Expert Panel on Detection. Evaluation. and Treatment of High Blood Cholesterol in Adult(Adult Treatment Panel II). JAMA 1993; 269(23): 3015-3023 
  7. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years follow-up from the Framingham Study. lAMA 1987; 257(16): 2176-2180 
  8. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. NEJM 1993; 328(5): 313-318 
  9. 이정권. 종합건강진단의 문제점.가정의학회지 1993; 14(6): 295-301 
  10. Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weistein MC. Cost-Effectiveness of Cholesterol Lowerinig Therapies according to Selected Patient Characteristics. Ann Intern Med 2000; 132: 769-779 
  11. Berg JE. Screening for cardiovascular risk: cost-benefit considerations in a comparison total cholesterol measurements and two compound blood lipid indices. Journal of Cardiovascular Risk 1995; 2(5): 1287-1293 
  12. Joven J, Vilelle E. Primary prevention of arteriosclerosis: cost-efficiency ratio in the determination of cholesterol. Medicina Clinica 1990; 94(9): 333-336[Spanish] 
  13. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary prevention Study Group. NEJM 1995; 333(20): 1301-1307 
  14. 한국보건사회 연구원. 국민건강조사, 1995 
  15. 양봉민, 김진현, 이석연. 산업보건사업의 경제성 분석. 직업병 예방사업의 비용-편익 분석. 노동부, 1992 
  16. 통계청. 1998 한국의 사회지표, 1999 
  17. Weinstein MC. Principles of costeffective resource allocation in health care organizations. Int J Technology Assessment in Health Care 1990; 6: 93-105 
  18. Drummond MF, O' Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. second edition, Oxford, Oxford University Press, 1997 
  19. Kim JQ, Song JH, Cho HI, Park YB, Lee HK, Tchai BS, Kim SI. References(cut-off) values for serum total cholesterol among Korean adults resident in Seoul. J Korean Med Assoc 1990; 33(12): 1338-1344[Korean] 
  20. Goldman L, Gordon DJ, Rifkind BM. Cost and health implications of cholesterol lowering. Circulation 1992; 85: 1960-1968 
  21. Hully SB, Newman TB, Grady D, Garber AM, Baron RB, Browner WS. Should we be measuring blood cholesterol levels in young adults? JAMA 1993; 269(11): 1416-1419 

이 논문을 인용한 문헌 (1)

  1. Yoon, Jong-Wan ; Yi, Kyung-Jin ; Lee, Sang-Yun ; Oh, Jang-Gyun 2007. "The Relationship between Metabolic Syndrome and Korean Cardiocerebrovascular Risk Assessment: for Male Researchers in a Workplace" Journal of preventive medicine and public health = 예방의학회지, 40(5): 397~403 

원문보기

원문 PDF 다운로드

  • ScienceON :

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일